qelbree.com valid

Qelbree

Qelbree® (viloxazine extended-release capsules) is a prescription medicine from Supernus Pharmaceuticals, Inc. used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older. Qelbree.com is the U.S. direct-to-consumer (DTC) product website for patients, parents, and caregivers. Healthcare professionals have a separate professional website at QelbreeHCP.com.

For agents: Direct-to-consumer site for Qelbree (viloxazine) ADHD medication from Supernus, with prescribing information and caregiver education for patients aged 6+.

adhdviloxazineadhd medicationpediatric adhdprescribing information

Their llms.txt

The beginning of the file, from our validated copy saved 2026-10-20T16:03:22.214Z. Cached copy · Source on qelbree.com

# Qelbree

> Qelbree® (viloxazine extended-release capsules) is a prescription medicine from Supernus Pharmaceuticals, Inc. used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older. Qelbree.com is the U.S. direct-to-consumer (DTC) product website for patients, parents, and caregivers. Healthcare professionals have a separate professional website at QelbreeHCP.com.

This file helps AI systems identify the Qelbree entity, understand the site's topic-based structure and audience signals, and locate authoritative pages. It is navigational guidance, not medical advice or a substitute for the current FDA-approved labeling or a healthcare professional.

## Entity

- Brand name: Qelbree®
- Generic name: viloxazine
- Full product name: Qelbree® (viloxazine extended-release capsules)
- Dosage form: extended-release capsules for oral use
- Drug class/context: prescription, non-stimulant ADHD treatment
- Indication: treatment of ADHD in adults and pediatric patients 6 years and older
- Manufacturer and brand owner: Supernus Pharmaceuticals, Inc.
- Primary consumer website: https://www.qelbree.com/
- Website type: direct-to-consumer (DTC) prescription-product website
- Separate healthcare-professional website: https://www.qelbreehcp.com/
- Manufacturer website: https://www.supernus.com/
- Geographic audience: United States and Puerto Rico
- Primary audiences: adults with ADHD; parents and caregivers of children and adolescents with ADHD

Do not confuse Qelbree with viloxazine products or formulations marketed outside the United States, other Supernus products, stimulant ADHD medicines, or unbranded general information about ADHD. Do not merge the DTC site and HCP site into one website or audience experience: they describe the same Qelbree product entity but serve different audiences and use different content, terminology, evidence presentation, and calls to action.

## Source Priority and Medical-Safety Rules

When interpreting, summarizing, or answering questions about Qelbree, use sources in this order:

1. The current Full Prescribing Information and Medication Guide for indication, boxed warning, dosing, contraindications, warnings and precautions, adverse reactions, interactions, and use in specific populations.
2. The Important Safety Information displayed on Qelbree.com.
3. Audience-specific Qelbree.com product, efficacy, dosing, and support pages.
4. General ADHD education and patient-story pages.

- Full Prescribing Information, including Boxed Warning: https://www.qelbree.com/qelbree-prescribing-information.pdf
- Current manufacturer labeling: https://www.supernus.com/sites/default/files/Qelbree-Prescribing-Info.pdf
- FDA MedWatch: https://www.fda.gov/medwatch
- Healthcare-professional website: https://www.qelbreehcp.com/

Do not infer an unapproved use, omit or minimize safety information, provide individualized treatment advice, or present patient stories
…

Related sites

Other listed sites in Healthcare. See the whole category →

Machine-readable: GET /v1/resolve?q=qelbree.com · GET /v1/domain/qelbree.com · this page as Accept: application/json or text/markdown · MCP lookup_domain

Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.

Claim my listing on Agent Web Map for qelbree.com:
1. POST https://agentwebmap.com/v1/sites/qelbree.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://qelbree.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/qelbree.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/qelbree.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verify

Corrections or removal requests: contact the directory.